zinc - Covid Index

Topics

Parent Topic

nutraceuticals

Information Sources addressing Topic

Case Report: Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients
Coronavirus Disease 2019 (COVID-19) Treatment Guidelines
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study
COVID-19: Poor outcomes in patients with zinc deficiency
Critical appraisal of multidrug therapy in the ambulatory management of patients with COVID-19 and hypoxemia
Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?
Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients
Low zinc levels at clinical admission associates with poor outcomes in COVID-19
Lower zinc levels in the blood are associated with an increased risk of death in patients with COVID-19
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection
The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis
Therapies to Prevent Progression of COVID-19, Including Hydroxychloroquine, Azithromycin, Zinc, and Vitamin D3 With or Without Intravenous Vitamin C: An International, Multicenter, Randomized Trial
Zinc supplementation and COVID-19 mortality: a meta-analysis
Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture

Topic ID

1026

© 2023 - 2025 The Covid Index. All rights reserved.